Alltrna is a biopharmaceutical company pioneering the development of tRNA therapeutics to address a wide array of diseases driven by shared genetic mutations. Founded in 2018 by Flagship Pioneering, Alltrna's mission revolves around unlocking the complexities of tRNA biology through advanced artificial intelligence and machine learning tools. This unique platform enables the design and delivery of diverse, programmable therapeutic molecules aimed at correcting disease at the molecular level. Alltrna's ambitious approach has the potential to unify treatment pathways across numerous conditions, making significant strides toward improving patient outcomes. Their core values emphasize a commitment to patient needs, curiosity as a catalyst for discovery, courage to embrace innovation, collaboration as a unified team, and a shared purpose in transforming medicine for patients everywhere.